Harri Hemilä

6.4k total citations · 2 hit papers
112 papers, 3.8k citations indexed

About

Harri Hemilä is a scholar working on Nutrition and Dietetics, Biochemistry and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Harri Hemilä has authored 112 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Nutrition and Dietetics, 22 papers in Biochemistry and 13 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Harri Hemilä's work include Vitamin C and Antioxidants Research (62 papers), Antioxidant Activity and Oxidative Stress (22 papers) and Vitamin K Research Studies (18 papers). Harri Hemilä is often cited by papers focused on Vitamin C and Antioxidants Research (62 papers), Antioxidant Activity and Oxidative Stress (22 papers) and Vitamin K Research Studies (18 papers). Harri Hemilä collaborates with scholars based in Finland, Australia and United States. Harri Hemilä's co-authors include Elizabeth Chalker, Jaakko Kaprio, Pekka Louhiala, Ilkka Palva, Robert M. Douglas, Demetrius Albanes, Mårten Wikström, Jarmo Virtamo, Teija Koivula and Peter Roberts‎ and has published in prestigious journals such as American Journal of Epidemiology, FEBS Letters and Cochrane Database of Systematic Reviews.

In The Last Decade

Harri Hemilä

107 papers receiving 3.6k citations

Hit Papers

Vitamin C for preventing and treating the common cold 2013 2026 2017 2021 2013 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harri Hemilä Finland 32 2.1k 607 561 520 474 112 3.8k
Silvia Maggini Switzerland 21 2.4k 1.2× 716 1.2× 791 1.4× 492 0.9× 303 0.6× 29 4.9k
Sudhir Dutta United States 28 832 0.4× 439 0.7× 262 0.5× 740 1.4× 363 0.8× 108 3.6k
Margarida Castell Spain 36 1.4k 0.7× 376 0.6× 181 0.3× 1.1k 2.1× 583 1.2× 168 3.9k
D. Hornig Switzerland 20 1.6k 0.7× 179 0.3× 401 0.7× 351 0.7× 272 0.6× 56 2.9k
Jordi Camps Spain 46 637 0.3× 243 0.4× 269 0.5× 1.4k 2.7× 334 0.7× 252 7.1k
Smaragdi Antonopoulou Greece 35 948 0.5× 174 0.3× 283 0.5× 904 1.7× 601 1.3× 153 3.9k
Aiguo Ma China 26 653 0.3× 439 0.7× 285 0.5× 701 1.3× 299 0.6× 145 2.9k
Valerie Burke Australia 55 2.6k 1.2× 177 0.3× 819 1.5× 942 1.8× 890 1.9× 170 9.0k
Francisco J. Pérez‐Cano Spain 36 1.6k 0.8× 439 0.7× 103 0.2× 1.1k 2.1× 392 0.8× 154 3.8k
David S. Rampton United Kingdom 51 561 0.3× 625 1.0× 243 0.4× 1.1k 2.1× 141 0.3× 128 7.8k

Countries citing papers authored by Harri Hemilä

Since Specialization
Citations

This map shows the geographic impact of Harri Hemilä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harri Hemilä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harri Hemilä more than expected).

Fields of papers citing papers by Harri Hemilä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harri Hemilä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harri Hemilä. The network helps show where Harri Hemilä may publish in the future.

Co-authorship network of co-authors of Harri Hemilä

This figure shows the co-authorship network connecting the top 25 collaborators of Harri Hemilä. A scholar is included among the top collaborators of Harri Hemilä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harri Hemilä. Harri Hemilä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hemilä, Harri, Elizabeth Chalker, & Janne Tukiainen. (2024). Response: Commentary: Quantile treatment effect of zinc lozenges on common cold duration: a novel approach to analyze the effect of treatment on illness duration. Frontiers in Pharmacology. 15. 1335784–1335784. 2 indexed citations
2.
Hemilä, Harri & A. Man. (2024). Vitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports. BMC Pulmonary Medicine. 24(1). 9 indexed citations
3.
Hemilä, Harri & Elizabeth Chalker. (2024). Evidence-based treatment of the common cold with zinc lozenges. Advances in Integrative Medicine. 11(2). 113–114. 1 indexed citations
4.
Hemilä, Harri & Elizabeth Chalker. (2023). Vitamin C reduces the severity of common colds: a meta-analysis. BMC Public Health. 23(1). 2468–2468. 14 indexed citations
5.
Hemilä, Harri, et al.. (2023). Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis. BMC Cardiovascular Disorders. 23(1). 475–475. 8 indexed citations
6.
Hemilä, Harri & Elizabeth Chalker. (2022). Abrupt termination of vitamin C from ICU patients may increase mortality: secondary analysis of the LOVIT trial. European Journal of Clinical Nutrition. 77(4). 490–494. 17 indexed citations
7.
Hemilä, Harri & Elizabeth Chalker. (2022). Bias against Vitamin C in Mainstream Medicine: Examples from Trials of Vitamin C for Infections. Life. 12(1). 62–62. 8 indexed citations
8.
Hemilä, Harri & Elizabeth Chalker. (2021). Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re‐analysis of randomized trial data. Pharmacology Research & Perspectives. 9(4). e00810–e00810. 23 indexed citations
11.
Hemilä, Harri, et al.. (2020). Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial. BMJ Open. 10(1). e031662–e031662. 16 indexed citations
12.
Hemilä, Harri & Elizabeth Chalker. (2020). Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis. Journal of Intensive Care. 8(1). 15–15. 94 indexed citations
13.
Hemilä, Harri & Elizabeth Chalker. (2019). Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis. Nutrients. 11(4). 708–708. 188 indexed citations
14.
Hemilä, Harri & Jan O. Friedrich. (2019). Many continuous variables should be analyzed using the relative scale: a case study of β2-agonists for preventing exercise-induced bronchoconstriction. Systematic Reviews. 8(1). 282–282. 4 indexed citations
15.
Hemilä, Harri. (2017). Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale: a case study of two zinc lozenge trials. BMC Medical Research Methodology. 17(1). 82–82. 12 indexed citations
16.
Hemilä, Harri. (2017). Vitamin C and Infections. Nutrients. 9(4). 339–339. 327 indexed citations breakdown →
17.
Hemilä, Harri. (2016). Vitamin E and the risk of pneumonia: using the I2 statistic to quantify heterogeneity within a controlled trial. British Journal Of Nutrition. 116(9). 1530–1536. 9 indexed citations
18.
Hemilä, Harri. (2006). Do vitamins C and E affect respiratory infections?. Työväentutkimus Vuosikirja. 23 indexed citations
19.
Hemilä, Harri & Robert M. Douglas. (1999). Vitamin C and acute respiratory infections.. PubMed. 3(9). 756–61. 55 indexed citations
20.
Hemilä, Harri. (1997). Vitamin C supplementation and the common cold: was Linus Pauling right or wrong?. PubMed. 67(5). 329–35. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026